Susceptibility genes and B-chronic lymphocytic leukaemia

British Journal of Haematology

Volumn 139, Issue 5, 2007, Pages 762-771

  Slager, Susan L ^a   Kay, Neil E ^a   Fredericksen, Zachary S ^a   Wang, Alice H ^a   Liebow, Mark ^a   Cunningham, Julie M ^a   Vachon, Celine M ^a   Call, Timothy G ^a   Cerhan, James R ^a  

^a Mayo Clinic   (United States)

Author keywords

Candidate gene; Case control; Disease pathway; Genetic association; Genomic studies

Indexed keywords

B CELL LEUKEMIA; CASE CONTROL STUDY; CHRONIC LYMPHATIC LEUKEMIA; DISEASE SEVERITY; FOLLOW UP; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOMICS; HUMAN; IMMUNITY; INFLAMMATION; METHODOLOGY; PRIORITY JOURNAL; REVIEW; RISK; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; CASE-CONTROL STUDIES; FEMALE; GENES, NEOPLASM; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 36148965219     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2007.06872.x     Document Type: Review

References (70)

1. Au, W.Y., Fung, A., Wong, K.F., Chan, C.H. Liang, R. (2006) Tumor necrosis factor alpha promoter polymorphism and the risk of chronic lymphocytic leukemia and myeloma in the Chinese population. Leukemia & Lymphoma, 47, 2189 2193.
2. Auer, R.L., Jones, C., Mullenbach, R.A., Syndercombe-Court, D., Milligan, D.W., Fegan, C.D. Cotter, F.E. (2001) Role for CCG-trinucleotide repeats in the pathogenesis of chronic lymphocytic leukemia. Blood, 97, 509 515.
3. Benjamini, Y. Hochberg, Y. (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society. Series A, 57, 289 300.
4. Bogunia-Kubik, K., Mazur, G., Urbanowicz, I., Wrobel, T., Kuliczkowski, K., Wozniak, M. Lange, A. (2006) Lack of association between the TNF-alpha promoter gene polymorphism and susceptibility to B-cell chronic lymphocytic leukaemia. International journal of immunogenetics, 33, 21 24.
5. Cabrini, G., Falzoni, S., Forchap, S.L., Pellegatti, P., Balboni, A., Agostini, P., Cuneo, A., Castoldi, G., Baricordi, O.R. Di Virgilio, F. (2005) A His-155 to Tyr polymorphism confers gain-of-function to the human P2X7 receptor of human leukemic lymphocytes. Journal of Immunology, 175, 82 89.
6. Calin, G.A., Trapasso, F., Shimizu, M., Dumitru, C.D., Yendamuri, S., Godwin, A.K., Ferracin, M., Bernardi, G., Chatterjee, D., Baldassarre, G., Rattan, S., Alder, H., Mabuchi, H., Shiraishi, T., Hansen, L.L., Overgaard, J., Herlea, V., Mauro, F.R., Dighiero, G., Movsas, B., Rassenti, L., Kipps, T., Baffa, R., Fusco, A., Mori, M., Russo, G., Liu, C.G., Neuberg, D., Bullrich, F., Negrini, M. Croce, C.M. (2005) Familial cancer associated with a polymorphism in ARLTS1 (see comment). New England Journal of Medicine, 352, 1667 1676.
7. Cerhan, J.R., Ansell, S.M., Fredericksen, Z.S., Kay, N.E., Liebow, M., Call, T.G., Dogan, A., Cunningham, J.M., Wang, A.H., Liu-Mares, W., Macon, W.R., Jelinek, D., Witzig, T.E., Habermann, T.M. Slager, S.L. (2007) Genetic variation in 1253 immune and inflammation genes and risk of non-Hodgkin lymphoma. Blood, [Epub ahead of print].
8. Chapman, J.M., Cooper, J.D., Todd, J.A. Clayton, D.G. (2003) Detecting disease associations due to linkage disequilibrium using haplotype tags: a class of tests and the determinants of statistical power. Human Heredity, 56, 18 31.
9. Chiu, B.C., Kolar, C., Gapstur, S.M., Lawson, T., Anderson, J.R. Weisenburger, D.D. (2005) Association of NAT and GST polymorphisms with non-Hodgkin's lymphoma: a population-based case-control study. British Journal of Haematology, 128, 610 615.
10. De Roos, A.J., Gold, L.S., Wang, S., Hartge, P., Cerhan, J.R., Cozen, W., Yeager, M., Chanock, S., Rothman, N. Severson, R.K. (2006) Metabolic gene variants and risk of non-Hodgkin's lymphoma. Cancer Epidemiology, Biomarkers and Prevention, 15, 1647 1653.
11. Demeter, J., Porzsolt, F., Ramisch, S., Schmidt, D., Schmid, M. Messer, G. (1997) Polymorphism of the tumour necrosis factor-alpha and lymphotoxin-alpha genes in chronic lymphocytic leukaemia. British Journal of Haematology, 97, 107 112.
12. Feigelson, H.S., Rodriguez, C., Robertson, A.S., Jacobs, E.J., Calle, E.E., Reid, Y.A. Thun, M.J. (2001) Determinants of DNA yield and quality from buccal cell samples collected with mouthwash. Cancer Epidemiology, Biomarkers and Prevention, 10, 1005 1008.
13. Feigelson, H.S., Rodriguez, C., Welch, R., Hutchinson, A., Shao, W., Jacobs, K., Diver, W.R., Calle, E.E., Thun, M.J., Hunter, D.J., Thomas, G. Chanock, S.J. (2007) Successful genome-wide scan in paired blood and buccal samples. Cancer Epidemiology, Biomarkers and Prevention, 16, 1023 1025.
14. Frey, U.H., Nuckel, H., Sellmann, L., Siemer, D., Kuppers, R., Durig, J., Duhrsen, U. Siffert, W. (2006) The GNAS1 T393C polymorphism is associated with disease progression and survival in chronic lymphocytic leukemia. Clinical Cancer Research, 12, 5686 5692.
15. Goldin, L.R. Caporaso, N.E. (2007) Family studies in chronic lymphocytic leukaemia and other lymphoproliferative tumours. British Journal of Haematology, 139, 774 779.
16. Guzowski, D., Chandrasekaran, A., Gawel, C., Palma, J., Koenig, J., Wang, X.P., Dosik, M., Kaplan, M., Chu, C.C., Chavan, S., Furie, R., Albesiano, E., Chiorazzi, N. Goodwin, L. (2005) Analysis of single nucleotide polymorphisms in the promoter region of interleukin-10 by denaturing high-performance liquid chromatography. Journal of Biomolecular Techniques, 16, 154 166.
17. Hardenbol, P., Yu, F., Belmont, J., Mackenzie, J., Bruckner, C., Brundage, T., Boudreau, A., Chow, S., Eberle, J., Erbilgin, A., Falkowski, M., Fitzgerald, R., Ghose, S., Iartchouk, O., Jain, M., Karlin-Neumann, G., Lu, X., Miao, X., Moore, B., Moorhead, M., Namsaraev, E., Pasternak, S., Prakash, E., Tran, K., Wang, Z., Jones, H.B., Davis, R.W., Willis, T.D. Gibbs, R.A. (2005) Highly multiplexed molecular inversion probe genotyping: over 10,000 targeted SNPs genotyped in a single tube assay. Genome Research, 15, 269 275.
18. Hill, D.A., Wang, S.S., Cerhan, J.R., Davis, S., Cozen, W., Severson, R.K., Hartge, P., Wacholder, S., Yeager, M., Chanock, S.J. Rothman, N. (2006) Risk of non-Hodgkin lymphoma (NHL) in relation to germline variation in DNA repair and related genes. Blood, 108, 3161 3167.
19. Jaffe, E., Harris, N., Stein, H. Vardiman, J. (2001) Wolrd Health Organization Cassification of Tumours Pathology and Genetics, Tumours of Hematopoietic and Lymphoid Tissues. IARC Press, Lyon.
20. Jamroziak, K., Balcerczak, E., Smolewski, P., Robey, R.W., Cebula, B., Panczyk, M., Kowalczyk, M., Szmigielska-Kaplon, A., Mirowski, M., Bates, S.E. Robak, T. (2006) MDR1 (ABCB1) gene polymorphism C3435T is associated with P-glycoprotein activity in B-cell chronic lymphocytic leukemia. Pharmacol Reports, 58, 720 728.
21. Klinkov, A.A., Nikitin, E.A., Maiorova, O.V., Ivanov, M.A., Strelnikov, V.V., Babenko, O.V., Zemlyakova, V.V., Kuznetsova, E.B. Zaletayev, D.V. (2004) TNR/11q#1 trinucleotide (GCC)n repeat alleles and predisposition to acute and chronic leukemia. Annals of Human Genetics, 68, 362 366.
22. Kochethu, G., Delgado, J., Pepper, C., Starczynski, J., Hooper, L., Krishnan, S., Fegan, C. Pratt, G. (2006) Two germ line polymorphisms of the tumour suppressor gene p53 may influence the biology of chronic lymphocytic leukaemia. Leukemia Research, 30, 1113 1118.
23. Lan, Q., Zheng, T., Chanock, S., Zhang, Y., Shen, M., Wang, S.S., Berndt, S.I., Zahm, S.H., Holford, T.R., Leaderer, B., Yeager, M., Welch, R., Hosgood, D., Boyle, P. Rothman, N. (2007a) Genetic variants in caspase genes and susceptibility to non-Hodgkin lymphoma. Carcinogenesis, 28, 823 827.
24. Lan, Q., Zheng, T., Shen, M., Zhang, Y., Wang, S.S., Zahm, S.H., Holford, T.R., Leaderer, B., Boyle, P. Chanock, S. (2007b) Genetic polymorphisms in the oxidative stress pathway and susceptibility to non-Hodgkin lymphoma. Human Genetics, 121, 161 168.
25. Lemos, M.C., Cabrita, F.J., Silva, H.A., Vivan, M., Placido, F. Regateiro, F.J. (1999) Genetic polymorphism of CYP2D6, GSTM1 and NAT2 and susceptibility to haematological neoplasias. Carcinogenesis, 20, 1225 1229.
26. Lim, U., Wang, S.S., Hartge, P., Cozen, W., Kelemen, L.E., Chanock, S., Davis, S., Blair, A., Schenk, M., Rothman, N. Lan, Q. (2007) Gene-nutrient interactions among determinants of folate and one-carbon metabolism on the risk of non-Hodgkin lymphoma: NCI-SEER case-control study. Blood, 109, 3050 3059.
27. Machulla, H.K., Muller, L.P., Schaaf, A., Kujat, G., Schonermarck, U. Langner, J. (2001) Association of chronic lymphocytic leukemia with specific alleles of the HLA-DR4:DR53:DQ8 haplotype in German patients. International Journal of Cancer, 92, 203 207.
28. Mainou-Fowler, T., Dickinson, A., Taylor, P., Mounter, P., Jack, F., Proctor, S., Nordon, J. Middleton, P. (2000) Tumor necrosis factor gene polymorphisms in lymphoproliferative disease. Leukaemia & Lymphoma, 38, 547 552.
29. Montes-Ares, O., Moya-Quiles, M.R., Montes-Casado, M., Guerra-Perez, N., Campillo, J.A., Gonzalez, C., Lopez-Bermejo, A., Tamayo, M., Majado, M.J., Parrado, A., Muro, M., Marin, L. Alvarez-Lopez, M.R. (2006) Human leucocyte antigen-C in B chronic lymphocytic leukaemia. British Journal of Haematology, 135, 517 519.
30. Morton, L.M., Schenk, M., Hein, D.W., Davis, S., Zahm, S.H., Cozen, W., Cerhan, J.R., Hartge, P., Welch, R., Chanock, S.J., Rothman, N. Wang, S.S. (2006) Genetic variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2) and risk of non-Hodgkin lymphoma. Pharmacogenetics and Genomics, 16, 537 545.
31. Munzert, G., Kirchner, D., Stobbe, H., Bergmann, L., Schmid, R.M., Dohner, H. Heimpel, H. (2002) Tumor necrosis factor receptor-associated factor 1 gene overexpression in B-cell chronic lymphocytic leukemia: analysis of NF-kappa B/Rel-regulated inhibitors of apoptosis. Blood, 100, 3749 3756.
32. Ng, D., Toure, O., Fontaine, L., McMaster, M.L., Goldin, L.R., Caporaso, N. Toro, J.R. (2007) No association of ARLTS1 polymorphisms and risk for familial chronic lymphocytic leukaemia. British Journal of Haematology, 137, 173 175.
33. Nieters, A., Beckmann, L., Deeg, E. Becker, N. (2006) Gene polymorphisms in Toll-like receptors, interleukin-10, and interleukin-10 receptor alpha and lymphoma risk. Genes and Immunity, 7, 615 624.
34. Nuckel, H., Frey, U.H., Durig, J., Duhrsen, U. Siffert, W. (2004a) 1513A/C polymorphism in the P2X7 receptor gene in chronic lymphocytic leukemia: absence of correlation with clinical outcome. European Journal of Haematology, 72, 259 263.
35. Nuckel, H., Frey, U.H., Durig, J., Duhrsen, U. Siffert, W. (2004b) Methylenetetrahydrofolate reductase (MTHFR) gene 677C>T and 1298A>C polymorphisms are associated with differential apoptosis of leukemic B cells in vitro and disease progression in chronic lymphocytic leukemia. Leukemia, 18, 1816 1823.
36. Nuckel, H., Frey, U.H., Sellmann, L., Bau, M., Durig, J., Duhrsen, U. Siffert, W. (2006) Bax gene G(-248)A promoter polymorphism and chronic lymphocytic leukemia: lack of association with incidence, disease stage and progression-free survival (comment). Leukemia, 20, 724.
37. Nuckel, H., Frey, U.H., Bau, M., Sellmann, L., Stanelle, J., Durig, J., Jockel, K.H., Duhrsen, U. Siffert, W. (2007) Association of a novel regulatory polymorphism (-938C>A) in the BCL2 gene promoter with disease progression and survival in chronic lymphocytic leukemia. Blood, 109, 290 297.
38. Paynter, R.A., Skibola, D.R., Skibola, C.F., Buffler, P.A., Wiemels, J.L. Smith, M.T. (2006) Accuracy of multiplexed illumina platform-based single-nucleotide polymorphism genotyping compared between genomic and whole genome amplified dna collected from multiple sources. Cancer Epidemiology, Biomarkers and Prevention, 15, 2533 2536.
39. Pemberton, N.C., Paneesha, S., Hiller, L., Starczynski, J., Hooper, L., Pepper, C., Pratt, G. Fegan, C. (2006) The SDF-1G>A polymorphism at position 801 plays no role in multiple myeloma but may contribute to an inferior cause-specific survival in chronic lymphocytic leukemia. Leukemia & Lymphoma, 47, 1239 1244.
40. Perez-Chacon, G., Contreras-Martin, B., Cuni, S., Rosado, S., Martin-Donaire, T., Losada-Fernandez, I., Vargas, J.A., Jorda, J., Alvarez, N., Garcia-Marco, J. Perez-Aciego, P. (2005) Polymorphism in the CD5 gene promoter in B-cell chronic lymphocytic leukemia and mantle cell lymphoma. American Journal of Clinical Pathology, 123, 646 650.
41. Pritchard, J.K., Stephens, M. Donnelly, P. (2000) Inference of population structure using multilocus genotype data. Genetics, 155, 945 959.
42. Riemann, K., Becker, L., Struwe, H., Nuckel, H., Duhrsen, U., Alakus, H., Winde, G., Neuhauser, M., Rubben, H., Schmitz, K.J., Wohlschlaeger, J., Schmid, K.W. Siffert, W. (2006) No association of the NFKB1 insertion/deletion promoter polymorphism with survival in colorectal and renal cell carcinoma as well as disease progression in B-cell chronic lymphocytic leukemia. Pharmacogenetics & Genomics, 16, 783 788.
43. Ries, L., Melbert, D., Krapcho, M., Mariotto, A., Miller, B., Feuer, E., Clegg, L., Horner, M., Howlander, N., Eisner, M., Reichman, M. Edwards, B. (2007) SEER Cancer Statistics Review, 1975-2004. National Cancer Institute, Bethesda, MD.
44. Rudd, M.F., Sellick, G.S., Allinson, R., Matutes, E., Catovsky, D. Houlston, R.S. (2004) MTHFR polymorphisms and risk of chronic lymphocytic leukemia. Cancer Epidemiology, Biomarkers & Prevention, 13, 2268 2270.
45. Rudd, M.F., Sellick, G.S., Webb, E.L., Catovsky, D. Houlston, R.S. (2006) Variants in the ATM-BRCA2-CHEK2 axis predispose to chronic lymphocytic leukemia. Blood, 108, 638 644.
46. Schaid, D.J., Rowland, C.M., Tines, D.E., Jacobson, R.M. Poland, G.A. (2002) Score tests for association between traits and haplotypes when linkage phase is ambiguous. American Journal of Human Genetics, 70, 425 434.
47. Scott, L.J., Mohlke, K.L., Bonnycastle, L.L., Willer, C.J., Li, Y., Duren, W.L., Erdos, M.R., Stringham, H.M., Chines, P.S., Jackson, A.U., Prokunina-Olsson, L., Ding, C.-J., Swift, A.J., Narisu, N., Hu, T., Pruim, R., Xiao, R., Li, X.-Y., Conneely, K.N., Riebow, N.L., Sprau, A.G., Tong, M., White, P.P., Hetrick, K.N., Barnhart, M.W., Bark, C.W., Goldstein, J.L., Watkins, L., Xiang, F., Saramies, J., Buchanan, T.A., Watanabe, R.M., Valle, T.T., Kinnunen, L., Abecasis, G.R., Pugh, E.W., Doheny, K.F., Bergman, R.N., Tuomilehto, J., Collins, F.S. Boehnke, M. (2007) A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science, 316, 1341 1345.
48. Sellick, G.S., Rudd, M.F., Eve, P., Allinson, R., Matutes, E., Catovsky, D. Houlston, R.S. (2004) The P2X7 receptor gene A1513C polymorphism does not contribute to risk of familial or sporadic chronic lymphocytic leukemia. Cancer Epidemiology, Biomarkers and Prevention, 13, 1065 1067.
49. Sellick, G.S., Coleman, R.J., Talaban, R.V., Fleischmann, C., Rudd, M.F., Allinson, R., Catovsky, D. Houlston, R.S. (2005) Germline mutations in Dok1 do not predispose to chronic lymphocytic leukemia. Leukemia Research, 29, 59 61.
50. Sellick, G.S., Catovsky, D. Houlston, R.S. (2006a) Familial cancer associated with a polymorphism in ARLTS1 (comment). New England Journal of Medicine, 354, 1204 1205.
51. Sellick, G.S., Catovsky, D. Houlston, R.S. (2006b) Relationship between ARLTS1 polymorphisms and risk of chronic lymphocytic leukemia. Leukemia Research, 30, 1573 1576.
52. Shen, M., Zheng, T., Lan, Q., Zhang, Y., Zahm, S.H., Wang, S.S., Holford, T.R., Leaderer, B., Yeager, M., Welch, R., Kang, D., Boyle, P., Zhang, B., Zou, K., Zhu, Y., Chanock, S. Rothman, N. (2006) Polymorphisms in DNA repair genes and risk of non-Hodgkin lymphoma among women in Connecticut. Human Genetics, 119, 659 668.
53. Skogsberg, S., Tobin, G., Krober, A., Kienle, D., Thunberg, U., Aleskog, A., Karlsson, K., Laurell, A., Merup, M., Vilpo, J., Sundstrom, C., Roos, G., Jernberg-Wiklund, H., Dohner, H., Nilsson, K., Stilgenbauer, S. Rosenquist, R. (2006) The G(-248)A polymorphism in the promoter region of the Bax gene does not correlate with prognostic markers or overall survival in chronic lymphocytic leukemia (see comment). Leukemia, 20, 77 81.
54. Starczynski, J., Pepper, C., Pratt, G., Hooper, L., Thomas, A., Hoy, T., Milligan, D., Bentley, P. Fegan, C. (2003) The P2X7 receptor gene polymorphism 1513 A→C has no effect on clinical prognostic markers, in vitro sensitivity to fludarabine, Bcl-2 family protein expression or survival in B-cell chronic lymphocytic leukaemia. British Journal of Haematology, 123, 66 71.
55. Starczynski, J., Pepper, C., Pratt, G., Hooper, L., Thomas, A., Milligan, D., Bentley, P. Fegan, C. (2005) Common polymorphism G(-248)A in the promoter region of the bax gene results in significantly shorter survival in patients with chronic lymphocytic leukemia once treatment is initiated. Journal of Clinical Oncology, 23, 1514 1521.
56. Taylor, J. Tibshirani, R. (2006) A tail strength measure for assessing the overall univariate significance in a dataset. Biostatistics, 7, 167 181.
57. Thunberg, U., Tobin, G., Johnson, A., Soderberg, O., Padyukov, L., Hultdin, M., Klareskog, L., Enblad, G., Sundstrom, C., Roos, G. Rosenquist, R. (2002) Polymorphism in the P2X7 receptor gene and survival in chronic lymphocytic leukaemia. Lancet, 360, 1935 1939.
58. Wacholder, S., McLaughlin, J.K., Silverman, D.T. Mandel, J.S. (1992a) Selection of controls in case-control studies. I. Principles. American Journal of Epidemiology, 135, 1019 1028.
59. Wacholder, S., Silverman, D.T., McLaughlin, J.K. Mandel, J.S. (1992b) Selection of controls in case-control studies. II. Types of controls. American Journal of Epidemiology, 135, 1029 1041.
60. Wacholder, S., Chanock, S., Garcia-Closas, M., El Ghormli, L. Rothman, N. (2004) Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. Journal of the National Cancer Institute, 96, 434 442.
61. Wang, S.S., Cerhan, J.R., Hartge, P., Davis, S., Cozen, W., Severson, R.K., Chatterjee, N., Yeager, M., Chanock, S.J. Rothman, N. (2006a) Common genetic variants in proinflammatory and other immunoregulatory genes and risk for non-hodgkin lymphoma. Cancer Research, 66, 9771 9780.
62. Wang, S.S., Cozen, W., Severson, R.K., Hartge, P., Cerhan, J.R., Davis, S., Welch, R., Rothman, N. Chanock, S.J. (2006b) Cyclin D1 splice variant and risk for non-Hodgkin lymphoma. Human Genetics, 120, 297 300.
63. Wang, S.S., Davis, S., Cerhan, J.R., Hartge, P., Severson, R.K., Cozen, W., Lan, Q., Welch, R., Chanock, S.J. Rothman, N. (2006c) Polymorphisms in oxidative stress genes and risk for non-Hodgkin lymphoma. Carcinogenesis, 27, 1828 1834.
64. Wihlborg, C., Sjoberg, J., Intaglietta, M., Axdorph, U., Pisa, E.K. Pisa, P. (1999) Tumour necrosis factor-alpha cytokine promoter gene polymorphism in Hodgkin's disease and chronic lymphocytic leukaemia. British Journal of Haematology, 104, 346 349.
65. Wiley, J.S., Dao-Ung, L.P., Gu, B.J., Sluyter, R., Shemon, A.N., Li, C., Taper, J., Gallo, J. Manoharan, A. (2002) A loss-of-function polymorphic mutation in the cytolytic P2X7 receptor gene and chronic lymphocytic leukaemia: a molecular study. Lancet, 359, 1114 1119.
66. Wolf, S., Mertens, D., Pscherer, A., Schroeter, P., Winkler, D., Grone, H.J., Hofele, C., Hemminki, K., Kumar, R., Steineck, G., Dohner, H., Stilgenbauer, S. Lichter, P. (2006) Ala228 variant of trail receptor 1 affecting the ligand binding site is associated with chronic lymphocytic leukemia, mantle cell lymphoma, prostate cancer, head and neck squamous cell carcinoma and bladder cancer. International Journal of Cancer, 118, 1831 1835.
67. Yuille, M., Condie, A., Hudson, C., Kote-Jarai, Z., Stone, E., Eeles, R., Matutes, E., Catovsky, D. Houlston, R. (2002) Relationship between glutathione S-transferase M1, T1, and P1 polymorphisms and chronic lymphocytic leukemia. Blood, 99, 4216 4218.
68. Zapata, J.M., Krajewska, M., Krajewski, S., Kitada, S., Welsh, K., Monks, A., McCloskey, N., Gordon, J., Kipps, T.J., Gascoyne, R.D., Shabaik, A. Reed, J.C. (2000) TNFR-associated factor family protein expression in normal tissues and lymphoid malignancies. Journal of Immunology, 165, 5084 5096.
69. Zhang, L.Y., Ibbotson, R.E., Orchard, J.A., Gardiner, A.C., Seear, R.V., Chase, A.J., Oscier, D.G. Cross, N.C. (2003) P2X7 polymorphism and chronic lymphocytic leukaemia: lack of correlation with incidence, survival and abnormalities of chromosome 12. Leukemia, 17, 2097 2100.
70. Zhang, Y., Lan, Q., Rothman, N., Zhu, Y., Zahm, S.H., Wang, S.S., Holford, T.R., Leaderer, B., Boyle, P., Zhang, B., Zou, K., Chanock, S. Zheng, T. (2005) A putative exonic splicing polymorphism in the BCL6 gene and the risk of non-Hodgkin lymphoma. Journal of the National Cancer Institute, 97, 1616 1618.